您当前所在的位置:首页 > 产品中心 > 产品信息
Deslanoside_分子结构_CAS_17598-65-1)
点击图片或这里关闭

Deslanoside

产品号 DB01078 公司名称 DrugBank
CAS号 17598-65-1 公司网站 http://www.ualberta.ca/
分子式 C47H74O19 电 话 (780) 492-3111
分子量 943.07906 传 真
纯 度 电子邮件 david.wishart@ualberta.ca
保 存 Chembase数据库ID: 949

产品价格信息

请登录

产品别名

标题
Deslanoside
IUPAC标准名
4-[(1S,2S,5S,7R,10R,11S,14R,15S,16R)-11,16-dihydroxy-5-{[(2R,4S,5S,6R)-4-hydroxy-5-{[(2S,4S,5S,6R)-4-hydroxy-5-{[(2S,4S,5S,6R)-4-hydroxy-6-methyl-5-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-6-methyloxan-2-yl]oxy}-6-methyloxan-2-yl]oxy}-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecan-14-yl]-2,5-dihydrofuran-2-one
IUPAC传统名
deslanoside
商标名
Cedilanid-d
Deacetyllanatoside C

产品登记号

CAS号 17598-65-1

产品性质

疏水性(logP) 0.2

产品详细信息

详细说明 (English)
Item Information
Drug Groups approved
Description Deacetyllanatoside C. A cardiotonic glycoside from the leaves of Digitalis lanata. [PubChem]
Indication For the treatment and management of Congestive cardiac insufficiency, arrhythmias and heart failure.
Pharmacology Deslanoside is a cardiac glycoside used to treat congestive heart failure and supraventricular arrhythmias due to reentry mechanisms, and to control ventricular rate in the treatment of chronic atrial fibrillation.
Toxicity Symptoms of overdose include ventricular tachycardia, ventricular fibrillation, progressive bradyarrhythmias, or heart block.
Affected Organisms
Humans and other mammals
Absorption Little absorption from the gastrointestinal tract (40%).
Half Life 36 hours
Protein Binding 20%
External Links
Wikipedia

参考文献